Format
Sort by

Send to

Choose Destination

Links from Books

Items: 15

1.

Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.

Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE, Cai W.

Am J Nucl Med Mol Imaging. 2012 Jan 1;2(1):1-13.

2.

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T.

Cancer Res. 2006 Jun 1;66(11):5633-40. Erratum in: Cancer Res. 2006 Jul 1;66(13):6894. Pål, Selbo K [corrected to Selbo, Pål K]; Alok, Sinha K [corrected to Sinha, Alok K]; Sung, Chang K [corrected to Chang, Sung K].

3.

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro.

Wang Y, Fei D, Vanderlaan M, Song A.

Angiogenesis. 2004;7(4):335-45. Epub 2005 May 9.

PMID:
15886877
4.

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Hicklin DJ, Ellis LM.

J Clin Oncol. 2005 Feb 10;23(5):1011-27. Epub 2004 Dec 7. Review.

PMID:
15585754
5.

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.

Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Havlik E, Schima W, Traub-Weidinger T, Graf S, Beheshti M, Schmid M, Angelberger P, Dudczak R.

Q J Nucl Med Mol Imaging. 2004 Sep;48(3):198-206.

6.

Molecular targeting: targeting angiogenesis in solid tumors.

Soria JC, Fayette J, Armand JP.

Ann Oncol. 2004;15 Suppl 4:iv223-7. Review. No abstract available.

7.

Vascular endothelial growth factor: basic science and clinical progress.

Ferrara N.

Endocr Rev. 2004 Aug;25(4):581-611. Review.

PMID:
15294883
8.

Vascular endothelial growth factor as a target for anticancer therapy.

Ferrara N.

Oncologist. 2004;9 Suppl 1:2-10. Review.

9.

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.

Ferrara N, Hillan KJ, Gerber HP, Novotny W.

Nat Rev Drug Discov. 2004 May;3(5):391-400. Review. No abstract available.

PMID:
15136787
10.

Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy.

Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Hamilton G, Kurtaran A, Pirich C, Angelberger P, Dudczak R.

Ann Oncol. 2003 Aug;14(8):1274-7.

11.

The biology of VEGF and its receptors.

Ferrara N, Gerber HP, LeCouter J.

Nat Med. 2003 Jun;9(6):669-76. Review.

PMID:
12778165
12.

Role of angiogenesis in tumor growth and metastasis.

Folkman J.

Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8. Review.

PMID:
12516034
13.

Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy.

Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, Angelberger P, Dudczak R, Virgolini I.

Int J Cancer. 2001 Mar 15;91(6):789-96.

14.

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR.

Cancer Res. 1999 Jul 15;59(14):3374-8.

15.
Items per page

Supplemental Content

Write to the Help Desk